2011
DOI: 10.1007/s11426-010-4175-9
|View full text |Cite
|
Sign up to set email alerts
|

Chemoenzymatic synthesis of α2–3-sialylated carbohydrate epitopes

Abstract: Sialic acids are common terminal carbohydrates on cell surface. Together with internal carbohydrate structures, they play important roles in many physiological and pathological processes. In order to obtain α2–3-sialylated oligosaccharides, a highly efficient one-pot three-enzyme synthetic approach was applied. The P. multocida α2–3-sialyltransferase (PmST1) involved in the synthesis was a multifunctional enzyme with extremely flexible donor and acceptor substrate specificities. Sialyltransferase acceptors, in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 39 publications
0
12
0
Order By: Relevance
“…2, PmST1 exhibited promiscuous donor substrate specificity and catalyzed the transfer of sialic acids from in situ generated CMP-sialic acids to Galβ1–3GalNAcαProN 3 3 synthesized by the Step I to produce sialyltrisaccharides 10 – 15 containing different terminal sialic acid forms in good to excellent (85–97%) yields. The sialosides containing three natural occurring sialic acid forms, Neu5Acα2–3Galβ1–3GalNAcαProN 3 10 , 15 Neu5Gcα2–3Galβ1–3GalNAcαProN 3 11 , 15 and Kdnα2–3Galβ1–3GalNAcαProN 3 12 were obtained in 87%, 94%, and 89% yields, respectively, from ManNAc 4 , ManNGc 5 , and mannose 6 as six-carbon sialic acid precursors. Neu5Gc is a non-human sialic acid which is overexpressed in certain cancer cells.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…2, PmST1 exhibited promiscuous donor substrate specificity and catalyzed the transfer of sialic acids from in situ generated CMP-sialic acids to Galβ1–3GalNAcαProN 3 3 synthesized by the Step I to produce sialyltrisaccharides 10 – 15 containing different terminal sialic acid forms in good to excellent (85–97%) yields. The sialosides containing three natural occurring sialic acid forms, Neu5Acα2–3Galβ1–3GalNAcαProN 3 10 , 15 Neu5Gcα2–3Galβ1–3GalNAcαProN 3 11 , 15 and Kdnα2–3Galβ1–3GalNAcαProN 3 12 were obtained in 87%, 94%, and 89% yields, respectively, from ManNAc 4 , ManNGc 5 , and mannose 6 as six-carbon sialic acid precursors. Neu5Gc is a non-human sialic acid which is overexpressed in certain cancer cells.…”
Section: Resultsmentioning
confidence: 99%
“…8 These β1–3-linked galactodisaccharides 16–22 were then used as sialyltransferase acceptors in the Step II one-pot three-enzyme sialylation process for the synthesis of α2–3-linked sialosides containing Neu5Ac formed from ManNAc 4 as a sialic acid precursor. As shown in Table 1, preparative-scale sialylation of galacto- N -biose (GNB) Galβ1–3GalNAc 16 and Galβ1–3GalNAcβProN 3 17 by Neu5Ac formed from ManNAc and pyruvate successfully produced the sialylated products 3′-sialyl galacto- N -biose (GNB) Neu5Acα2–3Galβ1–3GalNAc 23 16 and Neu5cα2–3Galβ1–3GalNAcβProN 3 24 15 in 90% and 92% yields, respectively. The one-pot three-enzyme system was also applied in sialylation of biologically important T antigens Galβ1–3GalNAcα1- O -Ser and Galβ1–3GalNAcα1- O -Thr to produce the desired trisaccharide products 25 and 26 in excellent 86% and 89% yields, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…While the CAZy GT80 family α2–3-sialyltransferases (α2–3STs), such as multifunctional Pasteurella multocida sialyltransferase 1 (PmST1), 15 are quite specific in catalyzing α2–3-sialylation to only the terminal galactose residues in galactosides, 10, 1719 the α2–6-sialyltransferase (α2–6ST) activity of multifunctional Photobacterium damselae α2–6ST (Pd2,6ST) 20 can catalyze α2–6-sialylation to both terminal and internal galactose or GalNAc residues. 10, 12, 16, 17, 21 …”
Section: Introductionmentioning
confidence: 99%
“…15, 31, 32 Additionally, PmST1 has been shown to be promiscuous towards a wide range of CMP-sialic acid donors and galactoside acceptors. 15, 19, 4649 PmST1 has multiple functions (Figure 1) including (1) α2–3ST, (2) α2–6ST, (3) α2–3-sialidase, (4) α2–3-trans-sialidase, (5) donor hydrolysis, 15, 45 and (6) α2–6-trans-sialidase 50 activities activity. As the α2–6ST activity of PmST1 is much weaker than its α2–3ST activity especially at pH≥7.0, 15 PmST1 has been broadly used in highly efficient synthesis of α2–3-sialosides with in situ generation of CMP-sialic acids by a CMP-sialic acid synthetase with or without a sialic acid aldolase.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, several elegant chemical syntheses, [4][5][6][7] microbial and coupled enzymatic approaches, 8,9 and chemoenzymatic synthesis 10 have been developed for the synthesis of LNT and its derivatives. The reactivity-based one-pot synthesis has been demonstrated as a valuable way to prepare LNT and fucosyl LNT in a few steps from several specifically designed building blocks, 5 however, this strategy may not be amenable to preparation of other structurally similar HMOs.…”
Section: Introductionmentioning
confidence: 99%